BiomX CBO, Assaf Oron will be presenting on multiple topics and panel discussion at the 5th Annual Microbiome Movement – Drug Development Summit.  See below for the following topics and times.
Access full agenda here

Topic: A Novel Machine Learning Approach to Microbiome Based Biomarker Discovery
•The need and challenges in microbiome-based biomarker discovery
•Using a novel cloud based computational approach utilizing machine learning to identify biomarkers
•Sharing examples of biomarker discovery
Time: October 19, 2020 at 12:00pm EDT

Panel Discussion: Reviewing the Role of the Human Microbiome in Biomarker Discovery & Development
•When we think about PK, what does that mean for the different microbiome-based drug modalities (LBPs, small molecules, GMO, Natural products etc.)
• Highlighting the importance of dosing and dosing strategies and how that relates to PK/PD
• Discussing how regulatory agencies look at IBD biomarkers when assessing the relative efficacy of microbiome-based therapeutics
Time: October 19, 2020 at 12:30pm EDT

Topic: Customized Phage Therapies for Chronic Disease
•Phage therapy as a promising modality to eradicate harmful bacteria
•BX001 a topically administered phage cocktail for acne
•Phage therapy for treating IBD and PSC
Time: October 20, 2020 at 2:00pm EDT